- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 296.04M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 428.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 102.62M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $400K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$49.1M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$19.7M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $229.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $194.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $207.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $168.8M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $2.9M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $27.4M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $51.8M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $58M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $58.4M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $64.9M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $246.7M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $212.9M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $266.4M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $233.7M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.11 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $10.5M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $5.6M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $33.4M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $21.5M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$47.6M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$27.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$47.9M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$26.6M |
| Revenue | Q1 2026 · Mar 31, 2026 | $900K |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $800K |